The role of Siemens Healthineers in the COVID-19 pandemic
Jul 01, 2020
A message from Peter Harrison, Managing Director GB&I
The COVID-19 pandemic continues to provide a challenge for many of us, having caused significant disruption to both our personal and professional lives. The progress made in tackling the disease, however, is testament to how well we have adapted to this challenging situation. Of course, we must continue to remain vigilant, and we work closely with our customers in Great Britain and Ireland as the challenges we all face continue to evolve.
Yet positives also emerge during times of crisis. The importance of digitalisation in healthcare has never been clearer to see, with adoption of remote and smart technologies on the rise. A partnership approach to working with healthcare providers has also been present throughout – from our customer service and enterprise service teams working hand in hand with customers, to our voluntary participation in the Ventilator Challenge UK, supporting ventilator manufacturers to scale up production in a time of great need*.
At Siemens Healthineers, we are proud to be an integral part of the solution. The resilience of our people, combined with the innovation of our technology, and flexibility of our service offering has placed us in good stead in the battle against COVID-19. Rest assured that our commitment to supporting this battle is steadfast; we continue to work diligently to meet our customers’ evolving needs.
*Siemens Healthineers does not manufacture ventilators nor do ventilators feature within our product portfolio
Scroll through to see how we're aiding the fight against COVID-19
Diagnosis of COVID-19 and the role of Computed Tomography
We have delivered the first CT container solution to North Tees and Hartlepool NHS Foundation Trust, offering a separate environment for the scanning of non-COVID related examinations. Read the press release.
Bedside ultrasound to diagnose lung pathology and for vascular access in COVID-19 patients
Portable systems such as the ACUSON Juniper, ACUSON P500 and ACUSON Freestyle (cable-free ultrasound) are helpful in evaluating pleural abnormalities, detecting catheter malposition and treating pleural effusion1,2,3.
Lung Ultrasound - Quick Reference Card
Laboratory Diagnostics: answering the call on SARS-CoV-2 and COVID-19
We have expanded infectious-disease testing capabilities by developing a SARS-CoV-2 laboratory serology assay4 to detect presence of IgM and IgG antibodies in blood. This reveals if a person had COVID-19 even if they were asymptomatic or undiagnosed.
Easy handling, smooth workflow
Maintain the highest infection control standards
- Anti-microbial surface and washable mouse5
- Makes cleaning and disinfection as easy as possible
- Reduces microbial growth on the system
Blood gas testing at the point-of-care
We have two key blood gas analysis solutions:
Mobile chest X-ray for COVID-19 ICU patients
The MOBILETT Elara Max offers mobility and positioning flexibility even in tight spaces, with superb image quality. Whilst the MOBILETT XP Hybrid combines imaging power, quality and mobility. Polymobil Plus offers mobile versatility for a multitude of applications.
Remote support: Sharing knowledge from a distance
Configuring fluoroscopy systems at a time of high demand
The Clinical Application Support team can assist you with this if required by connecting remotely and adding the appropriate protocol.
Support beyond technology
Our UK-wide network of experts can support the NHS to:
- Optimise pathways and streamline operations while safeguarding patient experience
- Expand capabilities to meet the urgent demand for care
- Advance quality and precision of care – deploying innovation where relevant
Research & Innovation Support
- Short term solutions for COVID-19 diagnostics
- Support efficient operating procedures in telehealth settings
- Support for patients to actively participate in their care
- Developing AI-enabled tools to prioritise and streamline workloads
Press & Statements
GB&I Statement - COVID-19 Business Impact
Customer Service operations
COVID-19: open letter from Bernd Montag
CT container solution safely boosts imaging capacity at North Tees and Hartlepool NHS Foundation Trust
SARS-CoV-2 antibody test from Siemens Healthineers found to satisfy mass screening criteria in Public Health England evaluation
Siemens Healthineers now shipping worldwide total antibody test and molecular test kit for COVID-19 with expanded capacity
Siemens Healthineers starts delivery of test kit for coronavirus SARS-CoV-2, now CE-IVD Registered
Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test
System Decontamination Documents
Get in touch
For any questions, please click below to reach out to the press office.
2Reusz G, Csomos A, The role of ultrasound guidance for vascular access. Curr Opin Anaesthesiol. 2015 Dec;28(6):710-6. doi:
4In development; not available for sale. Future availability cannot be guaranteed.
6CE-marked for sale in the EU. This test has not been reviewed by the FDA. In the US, use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. Product availability may vary by country and is subject to regulatory requirements.
7≥ 14 days post-PCR positive test